# Sheffield Children's NHS Foundation Trust

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/sheffield-children-s-nhs-foundation-trust/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 29 |
| Citations | 118,724 |
| City | Sheffield |
| Country | GB |
| Description | Sheffield Children's NHS Foundation Trust is a research organisation in Sheffield, GB. OpenAlex records 2,445 works and 118,724 citations for it. 625 researchers list it as their most recent affiliation. |
| Homepage | https://www.sheffieldchildrens.nhs.uk/ |
| OpenAlex ID | https://openalex.org/I4210121472 |
| Researchers | 625 |
| ROR ID | https://ror.org/02md8hv62 |
| Type | healthcare |
| Works | 2,445 |

## University papers

Showing 12 of 33.

- [Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis](https://scholariq.org/papers/two-phase-3-trials-of-dupilumab-versus-placebo-in-atopic-dermatitis/)
- [Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*](https://scholariq.org/papers/tralokinumab-for-moderate-to-severe-atopic-dermatitis-results-from-two-52-week/)
- [New perspectives on epidermal barrier dysfunction in atopic dermatitis: Gene–environment interactions](https://scholariq.org/papers/new-perspectives-on-epidermal-barrier-dysfunction-in-atopic-dermatitis-gene/)
- [Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial](https://scholariq.org/papers/efficacy-and-safety-of-abrocitinib-in-adults-and-adolescents-with-moderate-to/)
- [Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical t](https://scholariq.org/papers/dupilumab-with-concomitant-topical-corticosteroid-treatment-in-adults-with/)
- [ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children](https://scholariq.org/papers/etfad-eadv-eczema-task-force-2020-position-paper-on-diagnosis-and-treatment-of/)
- [Conjunctivitis in dupilumab clinical trials](https://scholariq.org/papers/conjunctivitis-in-dupilumab-clinical-trials/)
- [Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial](https://scholariq.org/papers/efficacy-and-safety-of-dupilumab-with-concomitant-topical-corticosteroids-in/)
- [The DNA sequence and comparative analysis of human chromosome 20](https://scholariq.org/papers/the-dna-sequence-and-comparative-analysis-of-human-chromosome-20/)
- [Daily emollient during infancy for prevention of eczema: the BEEP randomised controlled trial](https://scholariq.org/papers/daily-emollient-during-infancy-for-prevention-of-eczema-the-beep-randomised/)
- [When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council](https://scholariq.org/papers/when-does-atopic-dermatitis-warrant-systemic-therapy-recommendations-from-an/)
- [Type 2 Inflammation Contributes to Skin Barrier Dysfunction in Atopic Dermatitis](https://scholariq.org/papers/type-2-inflammation-contributes-to-skin-barrier-dysfunction-in-atopic-dermatitis/)

## University researchers

- [Kelechi Ugonna](https://scholariq.org/researchers/kelechi-ugonna/)
- [Janine Reynolds](https://scholariq.org/researchers/janine-reynolds/)

## University top topics

Showing 8 of 25.

- [Genomics and Rare Diseases](https://scholariq.org/topics/genomics-and-rare-diseases/)
- [Connective tissue disorders research](https://scholariq.org/topics/connective-tissue-disorders-research/)
- [Metabolism and Genetic Disorders](https://scholariq.org/topics/metabolism-and-genetic-disorders/)
- [Genomic variations and chromosomal abnormalities](https://scholariq.org/topics/genomic-variations-and-chromosomal-abnormalities/)
- [BRCA gene mutations in cancer](https://scholariq.org/topics/brca-gene-mutations-in-cancer/)
- [Bone fractures and treatments](https://scholariq.org/topics/bone-fractures-and-treatments/)
- [Genetics and Neurodevelopmental Disorders](https://scholariq.org/topics/genetics-and-neurodevelopmental-disorders/)
- [Child Abuse and Related Trauma](https://scholariq.org/topics/child-abuse-and-related-trauma/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.